* OrthoPediatrics Corp KIDS.OQ KIDS.O is expected
to show a
rise in quarterly revenue when it reports results
* The Warsaw Indiana Indiana-based company is expected to
report
a 15.5% increase in revenue to $40.368 million from $34.95
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
* Refinitiv's mean analyst estimate for OrthoPediatrics
Corp is
for a loss of 23 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
OrthoPediatrics
Corp is $52, above its last closing price of $26.87.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.20 -0.22 -0.13 Beat 39.9
Mar. 31 2023 -0.37 -0.36 -0.30 Beat 17.8
Dec. 31 2022 -0.23 -0.25 -0.35 Missed -38.4
Sep. 30 2022 -0.20 -0.20 -0.07 Beat 65.7
Jun. -0.22 -0.21 -0.02 Beat 90.7
30 2022
Mar. 31 2022 -0.38 -0.37 -0.47 Missed -26.7
Dec. 31 2021 -0.31 -0.30 0.00 Beat 100
Sep. 30 2021 -0.28 -0.28 -0.11 Beat 60.5
This summary was machine generated November 4 at 03:06 GMT. All
figures in US dollars unless otherwise stated